CS1:PA:PA-Amundi IBEX 35 UCITS ETF Acc (EUR)

ETF | Others |

Last Closing

USD 316.55

Change

-5.65 (-1.75)%

Market Cap

USD 0.09B

Volume

835.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.18 (+0.38%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-5.90 (-1.00%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-4.94 (-1.17%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

-0.36 (-0.96%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.35 (-0.14%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-6.60 (-1.27%)

USD 8.92B
WLD:PA Lyxor UCITS MSCI World D-EUR

-3.72 (-1.00%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

-0.61 (-1.03%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

-0.18 (-0.90%)

USD 6.91B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

-1.58 (-0.94%)

USD 5.17B

ETFs Containing CS1:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.74% 92% A 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.74% 92% A 83% B
Trailing 12 Months  
Capital Gain 33.20% 90% A- 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.20% 90% A- 89% A-
Trailing 5 Years  
Capital Gain 52.22% 67% D+ 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 52.22% 66% D+ 73% C
Average Annual (5 Year Horizon)  
Capital Gain 15.40% 79% B- 77% C+
Dividend Return 15.40% 78% C+ 38% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.05% 51% F 40% F
Risk Adjusted Return 117.98% 92% A 48% F
Market Capitalization 0.09B 27% F 44% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.